Australia's Lowered Bowel Cancer Screening Age Expected to Place Strain on Healthcare System

Reducing the starting age for bowel cancer screening in Australia from 50 to 45 years old is expected to lead to better health outcomes, but also increase the burden on an already strained healthcare system, warn researchers from Flinders University. The expanded screening program is predicted to lead to an influx of younger adults requiring ongoing surveillance with regular colonoscopies, prompting the team to review current clinical guidelines.

Key Takeaways:

• The lowered screening age is expected to lead to an influx of younger adults requiring ongoing surveillance with regular colonoscopies, placing a strain on an already stretched healthcare system.
• The study surveyed almost 300 people at risk for bowel cancer, revealing that most participants, regardless of age, wanted more frequent bowel cancer surveillance than what is currently recommended in clinical guidelines.
• A significant percentage of participants preferred more frequent colonoscopies than current guidelines suggest, with 54.1% of younger adults and 58.1% of older adults preferring more frequent surveillance.
• Both groups supported incorporating faecal tests between surveillance colonoscopies, with 91.2% of younger participants and 93% of older adults in agreement.
• The study found that younger adults reported significantly higher levels of fear regarding bowel cancer, correlating with a preference for more frequent surveillance.
• The addition of faecal tests into existing colonoscopy-based surveillance protocols could allow for personalized strategies that extend the time between colonoscopies for those with negative results.

Statistics:

• 1 in 9 (11%) Australians diagnosed with bowel cancer are under the age of 50.
• The study surveyed almost 300 people at risk for bowel cancer, comprising younger adults (under 50 years) and older adults (50 years and above).
• 54.1% of younger adults and 58.1% of older adults preferred more frequent colonoscopies than current guidelines suggest.
• 91.2% of younger participants and 93% of older adults supported incorporating faecal tests between surveillance colonoscopies.
• 1 in 9 (11%) Australians diagnosed with bowel cancer are under the age of 50.

Sources:

• "The Impact of Age on Preferences for Colorectal Cancer Surveillance Strategies: Are Fecal Immunochemical Tests FIT for Surveillance?" by Maddison Dix, Sarah Cohen-Woods, Molla M. Wassie, Jean M. Winter, Carlene J. Wilson, Graeme P. Young, Charles Cock, and Erin L. Symonds (Cancer Medicine).
• Funding for the study was provided by an Australian National Health and Medical Research Council project grant (APP1160443).